The IRMA Community
Newsletters
Research IRM
Click a keyword to search titles using our InfoSci-OnDemand powered search:
|
Integrated Diagnosis of Hemopoietic Neoplasms: Principles and General Approach
Abstract
Hematopoietic neoplasms' molecular landscape and pathogenesis impact diagnosis and prognosis and ultimately guide personalized management. Genomic alterations determine the fate of the neoplastic clone and correlate with disease phenotypes. In myeloid neoplasms, mutations may drive neoplastic clones through one of the following tracks: ineffective hematopoiesis, with cytopenia and myelodysplasia; proliferation and arrested maturation in acute leukemia; failing to die, with orderly development in chronic leukemia and myeloproliferative neoplasms; or a combination of tracks with overlapping features of MDS/MPNs syndromes. Lymphoid neoplasms often correspond to specific maturation stages; of the immune system. Genetic abnormalities and hereditary disorders may predispose to hematologic neoplasms, necessitating their investigation in their diagnostic workup. Detecting clonal hematopoiesis is critical in the risk stratification of many hemopoietic neoplasms.
Related Content
Yiannis Koumpouros.
© 2026.
36 pages.
|
Antonios Archontis, Yiannis Koumpouros.
© 2026.
48 pages.
|
R Velmurugan, J Sudarvel, Ravi Thirumalaisamy.
© 2026.
24 pages.
|
S. Ida Evangeline.
© 2026.
20 pages.
|
Ramya Raghavan, Srusti Shankar Moger, SaiMahima Umesh, G N Bhuvana.
© 2026.
36 pages.
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
Tiago Manuel Horta Reis da Silva.
© 2026.
32 pages.
|
|
|